LUBRITEQ
LIVE

Serial Number

99465626

Owner

Carl Freudenberg KG

Attorney

Jessica S. Sachs

Filing Date

Oct 28, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LUBRITEQ Trademark

Serial Number: 99465626

LUBRITEQ is a trademark filed by Carl Freudenberg KG on October 28, 2025. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Carl Freudenberg KG (6 trademarks)

Hoehnerweg 2-4
Weinheim 69469 , DE

Entity Type: 30

Trademark Details

Filing Date

October 28, 2025

Registration Date

Not Registered

Goods & Services

Surgical, medical, dental and veterinary apparatus and instruments, namely, artificial and natural surfaces and surgical implants and accessories with hydrophilic coating, drug-device products with hydrophilic coatings, catheters, guidewires, introducers and sheaths, tubes, stents and stent delivery systems, endoscopic and minimally invasive instruments, surgical instruments, implants and implant delivery systems, drug delivery devices, wound care products and medical textiles, diagnostic and microfluidic devices, heart parts, artificial heart valves, articles for medical use for the contact with blood, especially tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and the extracorporeal circulation except vascular filtration devices; surgical implants, anti-thrombotic and anti-coagulative surgical implants, artificial and natural surfaces for medical purposes, especially for the intra- and extracorporal circulation, artificial and natural surfaces and surgical implants coated with heparin, heparin derivatives or macromolecular agents, articles for medical use and for the contact with blood coated with heparin, heparin derivatives or macromolecular agents, especially tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and the extracorporeal circulation , vascular filtration devices; artificial limbs, eyes and teeth; massage apparatus for medical use; medical devices, namely, artificial and natural surfaces and surgical implants with hydrophilic coating, drug-device products with hydrophilic coatings, catheters, guidewires, introducers and sheaths, tubes, stents and stent delivery systems, endoscopic and minimally invasive instruments, surgical instruments, implants and implant delivery systems, drug delivery devices, wound care products and medical textiles, diagnostic and microfluidic devices, heart parts, artificial heart valves, articles for medical use for the contact with blood, especially tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and the extracorporeal circulation except vascular filtration devices; surgical implants, anti-thrombotic and anti-coagulative surgical implants, artificial and natural surfaces for medical purposes, especially for the intra- and extracorporal circulation, artificial and natural surfaces and surgical implants coated with heparin, heparin derivatives or macromolecular agents, articles for medical use and for the contact with blood coated with heparin, heparin derivatives or macromolecular agents, especially tubes for blood, valves, container, bags, cans, needles, catheter and artificial parts for the cardiovascular system and the extracorporeal circulation , vascular filtration devices

Scientific and technological services, namely, scientific research, analysis, and testing in the field of hydrophilic coatings and research and design relating thereto; Industrial research in the field of hydrophilic coatings and design relating thereto; Industrial analysis of hydrophilic coatings, industrial research in the field of hydrophilic coatings and industrial design services; quality control for others; providing biochemical, pharmaceutical and medicine-technological research services; Product and scientific research and development in the field of coatings relating to medical devices; Commissioned product and scientific research, commissioned product development work and related consultancy in the field of coating surfaces for medical devices

Treatment of materials, namely, treatment of metals, polymers, elastomers, glass, ceramics, composites; commissioned application of coatings via a wet chemical process to medical devices surfaces; application of hydrophilic coatings via a wet chemical process to medical devices

Chemicals for use in industry and science and chemical preparations for use in photography; unprocessed plastics; biological preparations for use in industry and science; polymer resins in their raw state; polymeric substances with hydrophilic properties for use in manufacturing coatings for medical devices; chemical coatings in the nature of hydrophilic coatings for use in the manufacture of medical devices and pharmaceutical preparations; chemical compositions in the nature of hydrophilic coatings for use in the manufacture of polymer coatings for medical devices

Hydrophilic coatings for medical devices and veterinary devices; coatings for medical devices, for delivery of a wide range of pharmaceuticals, sold separately from the medical devices; Hydrophilic coatings for medical devices; hydrophilic coatings for medical devices; hydrophilic surface coatings for medical devices; hydrophilic polymer coatings for medical devices

Filing History

NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 16, 2026 GNFN
FINAL REFUSAL E-MAILED
Jun 16, 2026 GNFR
FINAL REFUSAL WRITTEN
Jun 16, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 15, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 15, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 12, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 12, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 12, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 12, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 28, 2025 MAFR
NEW APPLICATION ENTERED
Oct 28, 2025 NWAP